Accordingly, recent studies have indicated that GnRH peptides could be used as an efficient guide of anticancer compounds and imaging agents, which can selectively target tumor cells, increase the amount of these substances in tumor tissue, and prevent normal cells from unnecessary exposure. This evidence concerns the gene GNRH1 and neoplasm.